Development of TP-317 for the treatment of eosinophilic esophagitis
Ended Project Grant Awarded Last action
- Award ID
- R43AI145455
- Recipient
-
Thetis Pharmaceuticals LLC UEI QBDWD3M7YKM9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $293,722
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Branford, CT 06405, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $293,722 |
Quick answers
Who received award R43AI145455?
R43AI145455 was awarded to Thetis Pharmaceuticals LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 1, 2019.
How much is award R43AI145455 worth?
$293,722 has been obligated on R43AI145455.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award